← BioTransfer GEO Dataset Finder
GEO series

Splicing targeting approaches highlight actionable vulnerabilities in triple negative breast cancer

GSE254842 Homo sapiens Expression profiling by high throughput sequencing 9 samples Submitted 2025/03/11 Platform GPL24676
Summary
To investigate if pharmacological inhibition of splicing could uncover novel actionable vulnerabilities in TNBC, we profiled the genome-wide transcriptional changes elicited in MDA-MB-231 cells by treatment with Indisulam, that promote degradation of the splicing, and Pladienolide B, that impairs the activity of SF3B1.
Published in
Transient splicing inhibition causes persistent DNA damage and chemotherapy vulnerability in triple-negative breast cancer
Caggiano C, Petrera V, Ferri M et al. · Cell reports 2024 · PMID 39276346 · doi:10.1016/j.celrep.2024.114751
This dataset
Download

Direct links to NCBI, no account and no request form: the whole study as GSE254842_RAW.tar, processed values as the series matrix, the supplementary file directory, and per-sample supplementary files for any of the 9 samples. Raw sequencing reads are also available from ENA.

Also filed as BioProject PRJNA1072064 and SRA study SRP487495. Searching any of these in the dataset finder brings you back here.

Samples in this study

The sample list for this study is not cached yet. Press Sort into groups and it will be fetched from NCBI.

+ 9 more — browse all 9 samples with per-sample file links →

Similar datasets

Search all human RNA-seq datasets in GEO →

Share this dataset

Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.